Methods and systems for monitoring bioactive agent use

• US 20090271120A1
• Filed: 07/07/2008
• Published: 10/29/2009
• Est. Priority Date: 04/24/2008
• Status: Active Grant

• Current Assignee: Harvest Bio LLC
• Original Assignee: Searete LLC (Intellectual Ventures LLC)
• Inventors: Ishikawa, Muriel Y., Lord, Robert W., Levien, Royce A., Wood, Lowell L. JR., Hyde, Roderick A., Malamud, Mark A., Sweeney, Elizabeth A., Wood, Victoria Y.H., Leuthardt, Eric C.
• Granted Patent: US 8,606,592 B2
• Time in Patent Office: Days
• US Class Current: 702/19
• CPC Class Codes: G16H 70/40 relating to drugs, e.g. their side effects or intended usage
• CPC Class Codes: G16H 70/60 relating to pathologies

Abstract

Methods, computer program products, and systems are described that include accepting at least one indication of a bioactive agent use by an individual and/or assigning an artificial sensory experience to monitor at least one desired effect of the bioactive agent on the individual.

Claims

1-72. -72. (canceled)

73. A system, comprising:

an acceptor module;

an assigner module configured to assign an artificial sensory experience to monitor at least one desired effect of a bioactive agent on an individual.

74. The system of claim 73, wherein the acceptor module comprises:

a bioactive agent identification acceptor module.

75. The system of claim 73, wherein the acceptor module comprises:

a substance abuse indication acceptor module.

76. The system of claim 73, wherein the acceptor module comprises:

a nutraceutical identification acceptor module.

77. The system of claim 73, wherein the assigner module configured to assign an artificial sensory experience to monitor at least one desired effect of a bioactive agent on an individual comprises:

a sensate experience assigner module.

78. The system of claim 77, wherein the sensate experience assigner module comprises:

a stimulus assessor module.

79. The system of claim 73, wherein the assigner module configured to assign an artificial sensory experience to monitor at least one desired effect of a bioactive agent on an individual comprises:

an automated medical device receiver module.

80. The system of claim 73, wherein the assigner module configured to assign an artificial sensory experience to monitor at least one desired effect of a bioactive agent on an individual comprises:

an assigner module configured to assign a virtual world, a modification to a virtual world, a computer game, a modification to a computer game, a website, a modification to a website, an online course, or a modification to an online course.

81. The system of claim 73, wherein the assigner module configured to assign an artificial sensory experience to monitor at least one desired effect of a bioactive agent on an individual comprises:

a monitorer module.

82. The system of claim 73, wherein the assigner module configured to assign an artificial sensory experience to monitor at least one desired effect of a bioactive agent on an individual comprises:

a neurophysiological measurement monitorer module.

83. The system of claim 82, wherein the neurophysiological measurement monitorer module comprises:

a physiologic activity measurer module.

84. The system of claim 73, wherein the assigner module configured to assign an artificial sensory experience to monitor at least one desired effect of a bioactive agent on an individual comprises:

a brain activity surrogate marker measurer module.

85. The system of claim 73, wherein the assigner module configured to assign an artificial sensory experience to monitor at least one desired effect of a bioactive agent on an individual comprises:

a near real time measurer module.

86. The system of claim 73, wherein the assigner module configured to assign an artificial sensory experience to monitor at least one desired effect of a bioactive agent on an individual comprises:

a test function output measurer module.

87. The system of claim 73, wherein the assigner module configured to assign an artificial sensory experience to monitor at least one desired effect of a bioactive agent on an individual comprises:

an effect recorder module.

88. The system of claim 73, further comprising:

a reporter module.

89. The system of claim 88, wherein the reporter module comprises:

a third party reporter module.

90. The system of claim 88, wherein the reporter module comprises:

a compliance data reporter module.

91. The system of claim 88, wherein the reporter module comprises:

a selective reporter module.

92. The system of claim 73, further comprising:

a predictor module.

93. The system of claim 92, wherein the predictor module comprises:

an effect predictor module.

94. The system of claim 92, wherein the predictor module comprises:

a behavioral response predictor module.